Celiac disease is a worldwide autoimmune disorder characterized by gluten intolerance, and is associated with a number of serious clinical conditions. Even though the prevalence of celiac disease is about 1%, there is still no special therapy; therefore people with celiac disease have to follow a strict gluten-free diet.<br><br> <strong>Technology</strong><br> We offer a novel polyclonal IgY antibody for the treatment of Celiac Disease. The treatment is based on the application of polyclonal anti-CD3 or anti-CDPtTG antibodies, which recognize a specific pathogen peptide. The antibodies are able to bind CD3-peptides and to inhibit human autoantibodies against tTG, without activating the immune system. <br><br> The antibodies are produced in high quantities in the egg yolk of chicken through specific immunization.
firstname.lastname@example.org | TechnologieAllianz e.V.
Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.
27.03.2017 | TechnologieAllianz e.V.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
29.03.2017 | Materials Sciences
29.03.2017 | Physics and Astronomy
29.03.2017 | Earth Sciences